Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
2008年1月31日 - 9:39AM
PRニュース・ワイアー (英語)
SOUTH SAN FRANCISCO, Calif., Jan. 30 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc., (NASDAQ:MGRM) announced that it will
hold a conference call on Thursday, February 7, 2008 at 4:30 p.m.
(Eastern Time) to discuss fourth quarter 2007 financial results and
to discuss the outlook for 2008. The call will be hosted by Mr.
William D. Young, Chairman and CEO of Monogram. To participate in
the live teleconference, please call (877) 545-1409, or (719)
325-4855 for international callers, fifteen minutes before the
conference begins. Live audio of the call will be simultaneously
broadcast over the Internet and will be available to members of the
news media, investors and the general public. Following the live
broadcast, a replay of the call will also be available at (888)
203-1112 or (719) 457-0820 for international callers, through
Thursday, February 21, 2008. The replay passcode is 3649403. Access
to live and archived audio of the conference call will be available
by following the appropriate links at http://www.monogrambio.com/
and clicking on the Investor Relations link. The information
provided on the teleconference is only accurate at the time of the
conference call, and Monogram will take no responsibility for
providing updated information except as required by law. About
Monogram Biosciences, Inc. Monogram is advancing individualized
medicine by discovering, developing and marketing innovative
products to guide and improve treatment of serious infectious
diseases and cancer. The Company's products are designed to help
doctors optimize treatment regimens for their patients that lead to
better outcomes and reduced costs. The Company's technology is also
being used by numerous biopharmaceutical companies to develop new
and improved antiviral therapeutics and vaccines as well as
targeted cancer therapeutics. More information about the Company
and its technology can be found on its web site at
http://www.monogrambio.com/. contacts: Alfred G. Merriweather
Jeremiah Hall Chief Financial Officer Feinstein Kean Healthcare
Tel: 650 624-4576 Tel: 415 677-2700 DATASOURCE: Monogram
Biosciences, Inc. Contact: Alfred G. Merriweather, Chief Financial
Officer of Monogram Biosciences, Inc., +1-650-624-4576, ; Jeremiah
Hall of Feinstein Kean Healthcare, +1-415-677-2700, , for Monogram
Biosciences, Inc. Web site: http://www.monogrambio.com/
Copyright
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 6 2024 まで 7 2024
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 7 2023 まで 7 2024